The protective effects of beta-mangostin against sodium iodate-induced retinal ROS-mediated apoptosis through MEK/ERK and p53 signaling pathways
Previous studies have indicated that NaIO 3 induces intracellular reactive oxygen species (ROS) production and has been used as a model for age-related macular degeneration (AMD) due to the selective retinal pigment epithelium (RPE) cell damage it induces. Beta-mangostin (BM) is a xanthone-type natu...
Saved in:
Published in | Food & function Vol. 14; no. 24; pp. 1896 - 199 |
---|---|
Main Authors | , , , , , , , , |
Format | Journal Article |
Language | English |
Published |
England
Royal Society of Chemistry
11.12.2023
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | Previous studies have indicated that NaIO
3
induces intracellular reactive oxygen species (ROS) production and has been used as a model for age-related macular degeneration (AMD) due to the selective retinal pigment epithelium (RPE) cell damage it induces. Beta-mangostin (BM) is a xanthone-type natural compound isolated from
Cratoxylum arborescens
. The influence of BM on NaIO
3
-induced oxidative stress damage in ARPE-19 cells has not yet been elucidated. In this study, we investigated how BM protects ARPE-19 cells from NaIO
3
-induced ROS-mediated apoptosis. Our results revealed that BM notably improved cell viability and prevented ARPE-19 cell mitochondrial dysfunction mediated-apoptosis induced by NaIO
3
; it was mediated by significantly reduced NaIO
3
-upregulated ROS, cellular H
2
O
2
production and improved downregulated glutathione and catalase activities. Furthermore, we found that BM could suppress the expression of Bax, cleaved PARP, and cleaved caspase-3 by decreasing phosphorylation of MEK/ERK and p53 expression in NaIO
3
-induced ARPE-19 cells. At the same time, we also used MEK inhibitors (PD98059) to confirm the above phenomenon. Moreover, our animal experiments revealed that BM prevented NaIO
3
from causing retinal deformation; it led to thicker outer and inner nuclear layers and downregulated cleaved caspase-3 expression compared to the group receiving NaIO
3
only. Collectively, these results suggest that BM can protect the RPE and retina from NaIO
3
-induced apoptosis through ROS-mediated mitochondrial dysfunction involving the MEK/ERK and p53 signaling pathways.
Previous studies have indicated that NaIO
3
induces intracellular reactive oxygen species (ROS) production and has been used as a model for age-related macular degeneration (AMD) due to the selective retinal pigment epithelium (RPE) cell damage it induces. |
---|---|
AbstractList | Previous studies have indicated that NaIO
3
induces intracellular reactive oxygen species (ROS) production and has been used as a model for age-related macular degeneration (AMD) due to the selective retinal pigment epithelium (RPE) cell damage it induces. Beta-mangostin (BM) is a xanthone-type natural compound isolated from
Cratoxylum arborescens
. The influence of BM on NaIO
3
-induced oxidative stress damage in ARPE-19 cells has not yet been elucidated. In this study, we investigated how BM protects ARPE-19 cells from NaIO
3
-induced ROS-mediated apoptosis. Our results revealed that BM notably improved cell viability and prevented ARPE-19 cell mitochondrial dysfunction mediated-apoptosis induced by NaIO
3
; it was mediated by significantly reduced NaIO
3
-upregulated ROS, cellular H
2
O
2
production and improved downregulated glutathione and catalase activities. Furthermore, we found that BM could suppress the expression of Bax, cleaved PARP, and cleaved caspase-3 by decreasing phosphorylation of MEK/ERK and p53 expression in NaIO
3
-induced ARPE-19 cells. At the same time, we also used MEK inhibitors (PD98059) to confirm the above phenomenon. Moreover, our animal experiments revealed that BM prevented NaIO
3
from causing retinal deformation; it led to thicker outer and inner nuclear layers and downregulated cleaved caspase-3 expression compared to the group receiving NaIO
3
only. Collectively, these results suggest that BM can protect the RPE and retina from NaIO
3
-induced apoptosis through ROS-mediated mitochondrial dysfunction involving the MEK/ERK and p53 signaling pathways. Previous studies have indicated that NaIO 3 induces intracellular reactive oxygen species (ROS) production and has been used as a model for age-related macular degeneration (AMD) due to the selective retinal pigment epithelium (RPE) cell damage it induces. Beta-mangostin (BM) is a xanthone-type natural compound isolated from Cratoxylum arborescens . The influence of BM on NaIO 3 -induced oxidative stress damage in ARPE-19 cells has not yet been elucidated. In this study, we investigated how BM protects ARPE-19 cells from NaIO 3 -induced ROS-mediated apoptosis. Our results revealed that BM notably improved cell viability and prevented ARPE-19 cell mitochondrial dysfunction mediated-apoptosis induced by NaIO 3 ; it was mediated by significantly reduced NaIO 3 -upregulated ROS, cellular H 2 O 2 production and improved downregulated glutathione and catalase activities. Furthermore, we found that BM could suppress the expression of Bax, cleaved PARP, and cleaved caspase-3 by decreasing phosphorylation of MEK/ERK and p53 expression in NaIO 3 -induced ARPE-19 cells. At the same time, we also used MEK inhibitors (PD98059) to confirm the above phenomenon. Moreover, our animal experiments revealed that BM prevented NaIO 3 from causing retinal deformation; it led to thicker outer and inner nuclear layers and downregulated cleaved caspase-3 expression compared to the group receiving NaIO 3 only. Collectively, these results suggest that BM can protect the RPE and retina from NaIO 3 -induced apoptosis through ROS-mediated mitochondrial dysfunction involving the MEK/ERK and p53 signaling pathways. Previous studies have indicated that NaIO 3 induces intracellular reactive oxygen species (ROS) production and has been used as a model for age-related macular degeneration (AMD) due to the selective retinal pigment epithelium (RPE) cell damage it induces. Previous studies have indicated that NaIO induces intracellular reactive oxygen species (ROS) production and has been used as a model for age-related macular degeneration (AMD) due to the selective retinal pigment epithelium (RPE) cell damage it induces. Beta-mangostin (BM) is a xanthone-type natural compound isolated from . The influence of BM on NaIO -induced oxidative stress damage in ARPE-19 cells has not yet been elucidated. In this study, we investigated how BM protects ARPE-19 cells from NaIO -induced ROS-mediated apoptosis. Our results revealed that BM notably improved cell viability and prevented ARPE-19 cell mitochondrial dysfunction mediated-apoptosis induced by NaIO ; it was mediated by significantly reduced NaIO -upregulated ROS, cellular H O production and improved downregulated glutathione and catalase activities. Furthermore, we found that BM could suppress the expression of Bax, cleaved PARP, and cleaved caspase-3 by decreasing phosphorylation of MEK/ERK and p53 expression in NaIO -induced ARPE-19 cells. At the same time, we also used MEK inhibitors (PD98059) to confirm the above phenomenon. Moreover, our animal experiments revealed that BM prevented NaIO from causing retinal deformation; it led to thicker outer and inner nuclear layers and downregulated cleaved caspase-3 expression compared to the group receiving NaIO only. Collectively, these results suggest that BM can protect the RPE and retina from NaIO -induced apoptosis through ROS-mediated mitochondrial dysfunction involving the MEK/ERK and p53 signaling pathways. Previous studies have indicated that NaIO3 induces intracellular reactive oxygen species (ROS) production and has been used as a model for age-related macular degeneration (AMD) due to the selective retinal pigment epithelium (RPE) cell damage it induces. Beta-mangostin (BM) is a xanthone-type natural compound isolated from Cratoxylum arborescens. The influence of BM on NaIO3-induced oxidative stress damage in ARPE-19 cells has not yet been elucidated. In this study, we investigated how BM protects ARPE-19 cells from NaIO3-induced ROS-mediated apoptosis. Our results revealed that BM notably improved cell viability and prevented ARPE-19 cell mitochondrial dysfunction mediated-apoptosis induced by NaIO3; it was mediated by significantly reduced NaIO3-upregulated ROS, cellular H2O2 production and improved downregulated glutathione and catalase activities. Furthermore, we found that BM could suppress the expression of Bax, cleaved PARP, and cleaved caspase-3 by decreasing phosphorylation of MEK/ERK and p53 expression in NaIO3-induced ARPE-19 cells. At the same time, we also used MEK inhibitors (PD98059) to confirm the above phenomenon. Moreover, our animal experiments revealed that BM prevented NaIO3 from causing retinal deformation; it led to thicker outer and inner nuclear layers and downregulated cleaved caspase-3 expression compared to the group receiving NaIO3 only. Collectively, these results suggest that BM can protect the RPE and retina from NaIO3-induced apoptosis through ROS-mediated mitochondrial dysfunction involving the MEK/ERK and p53 signaling pathways.Previous studies have indicated that NaIO3 induces intracellular reactive oxygen species (ROS) production and has been used as a model for age-related macular degeneration (AMD) due to the selective retinal pigment epithelium (RPE) cell damage it induces. Beta-mangostin (BM) is a xanthone-type natural compound isolated from Cratoxylum arborescens. The influence of BM on NaIO3-induced oxidative stress damage in ARPE-19 cells has not yet been elucidated. In this study, we investigated how BM protects ARPE-19 cells from NaIO3-induced ROS-mediated apoptosis. Our results revealed that BM notably improved cell viability and prevented ARPE-19 cell mitochondrial dysfunction mediated-apoptosis induced by NaIO3; it was mediated by significantly reduced NaIO3-upregulated ROS, cellular H2O2 production and improved downregulated glutathione and catalase activities. Furthermore, we found that BM could suppress the expression of Bax, cleaved PARP, and cleaved caspase-3 by decreasing phosphorylation of MEK/ERK and p53 expression in NaIO3-induced ARPE-19 cells. At the same time, we also used MEK inhibitors (PD98059) to confirm the above phenomenon. Moreover, our animal experiments revealed that BM prevented NaIO3 from causing retinal deformation; it led to thicker outer and inner nuclear layers and downregulated cleaved caspase-3 expression compared to the group receiving NaIO3 only. Collectively, these results suggest that BM can protect the RPE and retina from NaIO3-induced apoptosis through ROS-mediated mitochondrial dysfunction involving the MEK/ERK and p53 signaling pathways. Previous studies have indicated that NaIO3 induces intracellular reactive oxygen species (ROS) production and has been used as a model for age-related macular degeneration (AMD) due to the selective retinal pigment epithelium (RPE) cell damage it induces. Beta-mangostin (BM) is a xanthone-type natural compound isolated from Cratoxylum arborescens. The influence of BM on NaIO3-induced oxidative stress damage in ARPE-19 cells has not yet been elucidated. In this study, we investigated how BM protects ARPE-19 cells from NaIO3-induced ROS-mediated apoptosis. Our results revealed that BM notably improved cell viability and prevented ARPE-19 cell mitochondrial dysfunction mediated-apoptosis induced by NaIO3; it was mediated by significantly reduced NaIO3-upregulated ROS, cellular H2O2 production and improved downregulated glutathione and catalase activities. Furthermore, we found that BM could suppress the expression of Bax, cleaved PARP, and cleaved caspase-3 by decreasing phosphorylation of MEK/ERK and p53 expression in NaIO3-induced ARPE-19 cells. At the same time, we also used MEK inhibitors (PD98059) to confirm the above phenomenon. Moreover, our animal experiments revealed that BM prevented NaIO3 from causing retinal deformation; it led to thicker outer and inner nuclear layers and downregulated cleaved caspase-3 expression compared to the group receiving NaIO3 only. Collectively, these results suggest that BM can protect the RPE and retina from NaIO3-induced apoptosis through ROS-mediated mitochondrial dysfunction involving the MEK/ERK and p53 signaling pathways. |
Author | Yeh, Jui-Hsuan Chen, Tzu-Chun Hsu, Min-Yen Wang, Inga Wang, Meilin Chang, Yuan-Yen Lin, Hui-Wen Tsou, Shang-Chun Lee, Yi-Ju |
AuthorAffiliation | Department of Nutrition Rehabilitation Sciences & Technology Chung Shan Medical University Chung Shan Medical University and Clinical Laboratory University of Wisconsin-Milwaukee Chung Shan Medical University Hospital Asia University Department of Microbiology and Immunology Department of Pathology School of Medicine Institute of Medicine Department of Optometry Chung Shan Medical University and Department of Ophthalmology |
AuthorAffiliation_xml | – sequence: 0 name: Chung Shan Medical University Hospital – sequence: 0 name: Department of Microbiology and Immunology – sequence: 0 name: Chung Shan Medical University – sequence: 0 name: School of Medicine – sequence: 0 name: Department of Pathology – sequence: 0 name: Rehabilitation Sciences & Technology – sequence: 0 name: Chung Shan Medical University and Clinical Laboratory – sequence: 0 name: Institute of Medicine – sequence: 0 name: Chung Shan Medical University and Department of Ophthalmology – sequence: 0 name: University of Wisconsin-Milwaukee – sequence: 0 name: Asia University – sequence: 0 name: Department of Nutrition – sequence: 0 name: Department of Optometry |
Author_xml | – sequence: 1 givenname: Yuan-Yen surname: Chang fullname: Chang, Yuan-Yen – sequence: 2 givenname: Meilin surname: Wang fullname: Wang, Meilin – sequence: 3 givenname: Jui-Hsuan surname: Yeh fullname: Yeh, Jui-Hsuan – sequence: 4 givenname: Shang-Chun surname: Tsou fullname: Tsou, Shang-Chun – sequence: 5 givenname: Tzu-Chun surname: Chen fullname: Chen, Tzu-Chun – sequence: 6 givenname: Min-Yen surname: Hsu fullname: Hsu, Min-Yen – sequence: 7 givenname: Yi-Ju surname: Lee fullname: Lee, Yi-Ju – sequence: 8 givenname: Inga surname: Wang fullname: Wang, Inga – sequence: 9 givenname: Hui-Wen surname: Lin fullname: Lin, Hui-Wen |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/37990840$$D View this record in MEDLINE/PubMed |
BookMark | eNptkl1rFTEQhoNUbK298V4JeCPC2myS_chlqacqrRyoFbxb5iSze1J2k22SVfov_MlGT1uhODczMM87zNdzsue8Q0Jelux9yYQ6NqL3TFR1C0_IAWeSF3XFvu_dx1LV--QoxmuWTSjVqvYZ2ReNUqyV7ID8utoinYNPqJP9gRT7PkeR-p5uMEExgRt8TNZRGMC6mGj0xi4Ttd5AwsI6s2g0NGBmYKSX66_FhMbmnKEw-zn5aCNN2-CXYUu_rM6PV5fnFJyhcyVotENWWTfQGdL2J9zGF-RpD2PEozt_SL6dra5OPxUX64-fT08uCi1Ek4q2KaXmQsiSg-Hc9HXVb6TGumEbxZDXpZRMilbUJZqGca2ywlRStlCaPLs4JG93dfPwNwvG1E02ahxHcOiX2PFW8bpSlVAZffMIvfZLyH1nSjHGVdM2LFOv76hlkzfQzcFOEG67-11n4N0O0MHHGLB_QErW_bll90Gcrf_e8iTD7BGsbYJkvUsB7Ph_yaudJET9UPrfe4jfgrupiQ |
CitedBy_id | crossref_primary_10_3389_fimmu_2024_1440309 crossref_primary_10_3390_antiox13050538 crossref_primary_10_1002_tox_24501 crossref_primary_10_1016_j_tiv_2025_106047 crossref_primary_10_1016_j_biopha_2024_117346 crossref_primary_10_1002_tox_24416 crossref_primary_10_1016_j_bioorg_2024_107968 |
Cites_doi | 10.1038/s41419-021-03673-0 10.1016/j.dental.2005.11.037 10.1016/j.phrs.2021.106032 10.1155/2015/919058 10.1002/tox.22449 10.2147/DDDT.S80625 10.1016/j.preteyeres.2020.100858 10.1159/000092991 10.3390/nu13124411 10.1016/j.neurobiolaging.2005.05.012 10.1186/s13578-022-00879-3 10.1089/ars.2021.0072 10.1186/s12929-019-0531-z 10.1016/j.biopha.2023.114710 10.1016/j.arr.2022.101619 10.3390/antiox12071379 10.1016/j.cellsig.2022.110487 10.3390/antiox10121870 10.1016/j.freeradbiomed.2022.12.004 10.1016/j.biocel.2014.11.018 10.1016/j.jep.2014.02.051 10.1016/j.arr.2023.102077 10.1039/D2FO02788G 10.7150/thno.71038 10.1089/ars.2009.3001 10.1371/journal.pone.0143663 10.1016/j.foodchem.2012.02.075 10.1038/cdd.2017.169 10.1039/np9961300265 10.1038/s41598-019-52172-y 10.1093/jmcb/mjac074 10.1248/bpb.34.47 10.1155/2021/8852759 10.2147/DDDT.S278414 10.3390/biom10030492 10.3390/antiox10071125 10.1002/ptr.2730 10.3390/ijms22094945 10.1179/1476830512Y.0000000011 10.3390/ijms22084056 10.1371/journal.pone.0030874 |
ContentType | Journal Article |
Copyright | Copyright Royal Society of Chemistry 2023 |
Copyright_xml | – notice: Copyright Royal Society of Chemistry 2023 |
DBID | AAYXX CITATION CGR CUY CVF ECM EIF NPM 7T5 7T7 7TO 7U7 8FD C1K FR3 H94 P64 7X8 |
DOI | 10.1039/d3fo03568a |
DatabaseName | CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed Immunology Abstracts Industrial and Applied Microbiology Abstracts (Microbiology A) Oncogenes and Growth Factors Abstracts Toxicology Abstracts Technology Research Database Environmental Sciences and Pollution Management Engineering Research Database AIDS and Cancer Research Abstracts Biotechnology and BioEngineering Abstracts MEDLINE - Academic |
DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) Oncogenes and Growth Factors Abstracts Technology Research Database Toxicology Abstracts AIDS and Cancer Research Abstracts Immunology Abstracts Engineering Research Database Industrial and Applied Microbiology Abstracts (Microbiology A) Biotechnology and BioEngineering Abstracts Environmental Sciences and Pollution Management MEDLINE - Academic |
DatabaseTitleList | CrossRef MEDLINE MEDLINE - Academic Oncogenes and Growth Factors Abstracts |
Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Diet & Clinical Nutrition |
EISSN | 2042-650X |
EndPage | 199 |
ExternalDocumentID | 37990840 10_1039_D3FO03568A d3fo03568a |
Genre | Journal Article |
GroupedDBID | --- -JG 0-7 0R~ 4.4 53G 705 7~J AAEMU AAHBH AAIWI AAJAE AANOJ AARTK AAWGC AAXHV ABASK ABDVN ABEMK ABJNI ABPDG ABRYZ ABXOH ACGFS ACLDK ACPRK ADMRA ADSRN AEFDR AENEX AENGV AESAV AETIL AFLYV AFOGI AFRAH AFVBQ AGEGJ AGRSR AGSTE AHGCF AKBGW ALMA_UNASSIGNED_HOLDINGS ANUXI APEMP ASKNT AUDPV AZFZN BLAPV BSQNT C6K EBS ECGLT EE0 EF- GGIMP H13 HZ~ H~N J3I O-G O9- P2P RAOCF RCNCU RNS RPMJG RRC RSCEA RVUXY SKF SKH SKJ SKM SKR SKZ SLC SLF AAYXX AFRZK AKMSF CITATION CGR CUY CVF ECM EIF NPM 7T5 7T7 7TO 7U7 8FD C1K FR3 H94 P64 7X8 |
ID | FETCH-LOGICAL-c337t-8714c233412ad22df65fb4ce670b90e261440438361ed702c9871d5448a1d9083 |
ISSN | 2042-6496 2042-650X |
IngestDate | Fri Jul 11 07:01:14 EDT 2025 Mon Jun 30 11:56:22 EDT 2025 Wed Feb 19 02:08:28 EST 2025 Tue Jul 01 03:03:01 EDT 2025 Thu Apr 24 23:09:36 EDT 2025 Tue Dec 17 20:58:39 EST 2024 |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 24 |
Language | English |
LinkModel | OpenURL |
MergedId | FETCHMERGED-LOGICAL-c337t-8714c233412ad22df65fb4ce670b90e261440438361ed702c9871d5448a1d9083 |
Notes | https://doi.org/10.1039/d3fo03568a Electronic supplementary information (ESI) available. See DOI ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 14 content type line 23 |
ORCID | 0000-0001-6395-4280 0000-0002-0738-8509 |
PMID | 37990840 |
PQID | 2900297870 |
PQPubID | 2047526 |
PageCount | 14 |
ParticipantIDs | crossref_primary_10_1039_D3FO03568A proquest_journals_2900297870 pubmed_primary_37990840 proquest_miscellaneous_2892659539 crossref_citationtrail_10_1039_D3FO03568A rsc_primary_d3fo03568a |
ProviderPackageCode | CITATION AAYXX |
PublicationCentury | 2000 |
PublicationDate | 2023-12-11 |
PublicationDateYYYYMMDD | 2023-12-11 |
PublicationDate_xml | – month: 12 year: 2023 text: 2023-12-11 day: 11 |
PublicationDecade | 2020 |
PublicationPlace | England |
PublicationPlace_xml | – name: England – name: Cambridge |
PublicationTitle | Food & function |
PublicationTitleAlternate | Food Funct |
PublicationYear | 2023 |
Publisher | Royal Society of Chemistry |
Publisher_xml | – name: Royal Society of Chemistry |
References | Nauman (D3FO03568A/cit11/1) 2022; 175 Chan (D3FO03568A/cit17/1) 2019; 26 Sidahmed (D3FO03568A/cit37/1) 2016; 10 Huang (D3FO03568A/cit24/1) 2017; 32 Kim (D3FO03568A/cit44/1) 2015; 59 Xing (D3FO03568A/cit9/1) 2021; 13 Syam (D3FO03568A/cit38/1) 2014; 153 Feher (D3FO03568A/cit27/1) 2006; 27 Alam (D3FO03568A/cit36/1) 2023; 163 Hsu (D3FO03568A/cit4/1) 2021; 10 Lee (D3FO03568A/cit13/1) 2019; 2019 Zou (D3FO03568A/cit29/1) 2023; 194 Deng (D3FO03568A/cit30/1) 2021; 2021 Yang (D3FO03568A/cit42/1) 2023 Bai (D3FO03568A/cit1/1) 2022; 77 Li (D3FO03568A/cit14/1) 2020; 14 Obolskiy (D3FO03568A/cit34/1) 2009; 23 Yuan (D3FO03568A/cit22/1) 2020; 2020 Wang (D3FO03568A/cit23/1) 2022; 12 Reyes-Fermín (D3FO03568A/cit40/1) 2012; 15 Duan (D3FO03568A/cit33/1) 2011; 34 Kaarniranta (D3FO03568A/cit20/1) 2020; 79 Feher (D3FO03568A/cit19/1) 2006; 27 Janhom (D3FO03568A/cit41/1) 2015; 2015 Lee (D3FO03568A/cit32/1) 2020; 10 Lu (D3FO03568A/cit10/1) 2021; 22 Aubrey (D3FO03568A/cit43/1) 2018; 25 Mueller (D3FO03568A/cit26/1) 2012; 7 Zheng (D3FO03568A/cit18/1) 2023; 14 Hao (D3FO03568A/cit21/1) 2022; 14 Ding (D3FO03568A/cit2/1) 2023; 91 Chang (D3FO03568A/cit47/1) 2015; 10 Weecharangsan (D3FO03568A/cit39/1) 2006; 15 Nauman (D3FO03568A/cit35/1) 2022; 175 Chang (D3FO03568A/cit3/1) 2021; 22 Samuelsen (D3FO03568A/cit45/1) 2007; 23 Kumar (D3FO03568A/cit15/1) 2021; 12 Chuang (D3FO03568A/cit5/1) 2021; 10 Zeng (D3FO03568A/cit46/1) 2022; 12 Ahn (D3FO03568A/cit8/1) 2019; 9 Acosta-Casique (D3FO03568A/cit16/1) 2023; 101 Chae (D3FO03568A/cit12/1) 2012; 134 Kushwah (D3FO03568A/cit7/1) 2023; 12 Kietzmann (D3FO03568A/cit25/1) 2010; 13 Gordon (D3FO03568A/cit6/1) 1996; 13 Chen (D3FO03568A/cit31/1) 2022; 37 Kaarniranta (D3FO03568A/cit28/1) 2020; 79 |
References_xml | – volume: 12 start-page: 389 year: 2021 ident: D3FO03568A/cit15/1 publication-title: Cell Death Dis. doi: 10.1038/s41419-021-03673-0 – volume: 23 start-page: 34 year: 2007 ident: D3FO03568A/cit45/1 publication-title: Dent. Mater. doi: 10.1016/j.dental.2005.11.037 – volume: 175 start-page: 106032 year: 2022 ident: D3FO03568A/cit11/1 publication-title: Pharmacol. Res. doi: 10.1016/j.phrs.2021.106032 – volume: 2015 start-page: 919058 year: 2015 ident: D3FO03568A/cit41/1 publication-title: J. Toxicol. doi: 10.1155/2015/919058 – volume: 32 start-page: 2360 year: 2017 ident: D3FO03568A/cit24/1 publication-title: Environ. Toxicol. doi: 10.1002/tox.22449 – volume: 10 start-page: 297 year: 2016 ident: D3FO03568A/cit37/1 publication-title: Drug Des., Dev. Ther. doi: 10.2147/DDDT.S80625 – volume: 79 start-page: 100858 year: 2020 ident: D3FO03568A/cit28/1 publication-title: Prog. Retinal Eye Res. doi: 10.1016/j.preteyeres.2020.100858 – volume: 15 start-page: 281 year: 2006 ident: D3FO03568A/cit39/1 publication-title: Med. Princ. Pract. doi: 10.1159/000092991 – volume: 13 start-page: 4411 issue: 12 year: 2021 ident: D3FO03568A/cit9/1 publication-title: Nutrients doi: 10.3390/nu13124411 – volume: 2019 start-page: 3640753 year: 2019 ident: D3FO03568A/cit13/1 publication-title: Oxid. Med. Cell. Longevity – volume: 27 start-page: 983 year: 2006 ident: D3FO03568A/cit27/1 publication-title: Neurobiol. Aging doi: 10.1016/j.neurobiolaging.2005.05.012 – volume: 12 start-page: 133 year: 2022 ident: D3FO03568A/cit23/1 publication-title: Cell Biosci. doi: 10.1186/s13578-022-00879-3 – volume: 37 start-page: 115 issue: 1–3 year: 2022 ident: D3FO03568A/cit31/1 publication-title: Antioxid. Redox Signaling doi: 10.1089/ars.2021.0072 – volume: 26 start-page: 40 year: 2019 ident: D3FO03568A/cit17/1 publication-title: J. Biomed. Sci. doi: 10.1186/s12929-019-0531-z – volume: 163 start-page: 114710 year: 2023 ident: D3FO03568A/cit36/1 publication-title: Biomed. Pharmacother. doi: 10.1016/j.biopha.2023.114710 – volume: 77 start-page: 101619 year: 2022 ident: D3FO03568A/cit1/1 publication-title: Ageing Res. Rev. doi: 10.1016/j.arr.2022.101619 – volume: 12 start-page: 1379 issue: 7 year: 2023 ident: D3FO03568A/cit7/1 publication-title: Antioxidants doi: 10.3390/antiox12071379 – volume: 101 start-page: 110487 year: 2023 ident: D3FO03568A/cit16/1 publication-title: Cell. Signalling doi: 10.1016/j.cellsig.2022.110487 – volume: 10 start-page: 1870 year: 2021 ident: D3FO03568A/cit5/1 publication-title: Antioxidants doi: 10.3390/antiox10121870 – volume: 194 start-page: 209 year: 2023 ident: D3FO03568A/cit29/1 publication-title: Free Radicals Biol. Med. doi: 10.1016/j.freeradbiomed.2022.12.004 – volume: 59 start-page: 41 year: 2015 ident: D3FO03568A/cit44/1 publication-title: Int. J. Biochem. Cell Biol. doi: 10.1016/j.biocel.2014.11.018 – volume: 153 start-page: 435 year: 2014 ident: D3FO03568A/cit38/1 publication-title: J. Ethnopharmacol. doi: 10.1016/j.jep.2014.02.051 – volume: 91 start-page: 102077 year: 2023 ident: D3FO03568A/cit2/1 publication-title: Ageing Res. Rev. doi: 10.1016/j.arr.2023.102077 – volume: 14 start-page: 399 issue: 1 year: 2023 ident: D3FO03568A/cit18/1 publication-title: Food Funct. doi: 10.1039/D2FO02788G – volume: 12 start-page: 6705 issue: 15 year: 2022 ident: D3FO03568A/cit46/1 publication-title: Theranostics doi: 10.7150/thno.71038 – volume: 175 start-page: 106032 year: 2022 ident: D3FO03568A/cit35/1 publication-title: Pharmacol. Res. doi: 10.1016/j.phrs.2021.106032 – volume: 13 start-page: 395 year: 2010 ident: D3FO03568A/cit25/1 publication-title: Antioxid. Redox Signal. doi: 10.1089/ars.2009.3001 – volume: 10 start-page: e0143663 year: 2015 ident: D3FO03568A/cit47/1 publication-title: PLoS One doi: 10.1371/journal.pone.0143663 – volume: 134 start-page: 397 year: 2012 ident: D3FO03568A/cit12/1 publication-title: Food Chem. doi: 10.1016/j.foodchem.2012.02.075 – volume: 27 start-page: 983 year: 2006 ident: D3FO03568A/cit19/1 publication-title: Neurobiol. Aging doi: 10.1016/j.neurobiolaging.2005.05.012 – volume: 25 start-page: 104 year: 2018 ident: D3FO03568A/cit43/1 publication-title: Cell Death Differ. doi: 10.1038/cdd.2017.169 – volume: 13 start-page: 265 year: 1996 ident: D3FO03568A/cit6/1 publication-title: Nat. Prod. Rep. doi: 10.1039/np9961300265 – volume: 9 start-page: 15696 issue: 1 year: 2019 ident: D3FO03568A/cit8/1 publication-title: Sci. Rep. doi: 10.1038/s41598-019-52172-y – volume: 14 start-page: mjac074 issue: 10 year: 2022 ident: D3FO03568A/cit21/1 publication-title: J. Mol. Cell Biol. doi: 10.1093/jmcb/mjac074 – volume: 2020 start-page: 7962393 year: 2020 ident: D3FO03568A/cit22/1 publication-title: Oxid. Med. Cell. Longevity – volume: 34 start-page: 47 year: 2011 ident: D3FO03568A/cit33/1 publication-title: Biol. Pharm. Bull. doi: 10.1248/bpb.34.47 – volume: 2021 start-page: 8852759 year: 2021 ident: D3FO03568A/cit30/1 publication-title: Oxid. Med. Cell. Longevity doi: 10.1155/2021/8852759 – year: 2023 ident: D3FO03568A/cit42/1 publication-title: J. Adv. Res. – volume: 14 start-page: 5315 year: 2020 ident: D3FO03568A/cit14/1 publication-title: Drug Des., Dev. Ther. doi: 10.2147/DDDT.S278414 – volume: 10 start-page: 492 year: 2020 ident: D3FO03568A/cit32/1 publication-title: Biomolecules doi: 10.3390/biom10030492 – volume: 10 start-page: 1125 year: 2021 ident: D3FO03568A/cit4/1 publication-title: Antioxidants doi: 10.3390/antiox10071125 – volume: 23 start-page: 1047 year: 2009 ident: D3FO03568A/cit34/1 publication-title: Phytother. Res. doi: 10.1002/ptr.2730 – volume: 22 start-page: 4945 issue: 9 year: 2021 ident: D3FO03568A/cit10/1 publication-title: Int. J. Mol. Sci. doi: 10.3390/ijms22094945 – volume: 79 start-page: 100858 year: 2020 ident: D3FO03568A/cit20/1 publication-title: Prog. Retinal Eye Res. doi: 10.1016/j.preteyeres.2020.100858 – volume: 15 start-page: 34 year: 2012 ident: D3FO03568A/cit40/1 publication-title: Nutr. Neurosci. doi: 10.1179/1476830512Y.0000000011 – volume: 22 start-page: 4056 year: 2021 ident: D3FO03568A/cit3/1 publication-title: Int. J. Mol. Sci. doi: 10.3390/ijms22084056 – volume: 7 start-page: e30874 year: 2012 ident: D3FO03568A/cit26/1 publication-title: PLoS One doi: 10.1371/journal.pone.0030874 |
SSID | ssj0000399898 |
Score | 2.3764296 |
Snippet | Previous studies have indicated that NaIO
3
induces intracellular reactive oxygen species (ROS) production and has been used as a model for age-related macular... Previous studies have indicated that NaIO induces intracellular reactive oxygen species (ROS) production and has been used as a model for age-related macular... Previous studies have indicated that NaIO3 induces intracellular reactive oxygen species (ROS) production and has been used as a model for age-related macular... |
SourceID | proquest pubmed crossref rsc |
SourceType | Aggregation Database Index Database Enrichment Source Publisher |
StartPage | 1896 |
SubjectTerms | Age Age related diseases Animals Apoptosis Caspase 3 - genetics Caspase 3 - metabolism Caspase-3 Catalase Cell viability Cellular manufacture Damage Down-regulation Epithelium Eye diseases Glutathione Hydrogen peroxide Hydrogen Peroxide - metabolism Intracellular signalling Macular degeneration MEK inhibitors Mitochondrial Diseases Mitogen-Activated Protein Kinase Kinases - metabolism Oxidative Stress p53 Protein Phosphorylation Reactive oxygen species Reactive Oxygen Species - metabolism Retina Retinal Pigment Epithelium Signal Transduction Tumor Suppressor Protein p53 - genetics Tumor Suppressor Protein p53 - metabolism |
Title | The protective effects of beta-mangostin against sodium iodate-induced retinal ROS-mediated apoptosis through MEK/ERK and p53 signaling pathways |
URI | https://www.ncbi.nlm.nih.gov/pubmed/37990840 https://www.proquest.com/docview/2900297870 https://www.proquest.com/docview/2892659539 |
Volume | 14 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1bb9MwFLbK9sIL4jYoDGQEQkJVWGLn5sfStVR0a6XRau1T5CTOFqlLqjURgl_AIz-Z48S5VOvD4MWqTmwn6vl8fI59Lgh9cN3AYoL5muk7HBrX1phrmJrNIxG4luNEfuFtMbXHC_Pb0lp2Or9bXkt55n8Ofu2NK_kfrgIN-CqjZP-Bs_WkQIDfwF9ogcPQ3pvHKtGCdABq-Wb4IuPaDU-uUljCSY9f8Rj0wN42DeP8phen0s7XwBzP5fW_DGSUSunF7LtWRJJILZRv0k2WynQlVSmf8-EEPnV4MSmTC1i0J50_eBnPDorkD_5z29Z1RzJhskSW3Dvb9_2D6pB6lfNEWzXBaJeKfi7idVxTV-K6jB-JtfE2b9A836Z5cXgrp9MG13nSPsIgVLqDKBFbSDoiY4RAVVyWm9IeWiWqzRYkidkSvIbulpVx72wJOpUZVUMapTq1bLe18VWX_dOZN1qcnXnz4XL-AB0SMDhAYh72J1--XtbndTCNLLUpaxVWX1Zlu6XspJl-V7-5Y7SACnNblZYpVJj5Y_RI2R64XwLpCeqI5CnqnsYiwx-xShC7xtOqPsMz9AcAhhuAYQUwnEZ4F2BYAQyXAMO7AMMKYLgNMFwDDCuAYQDYCcALA7wwwAvX8MIVvJ6jxWg4H4w1VcJDCyh1MthrDTMgFFQlwkNCwsi2It8MhO3oPtMFkccRRbZc2xCho5OAwYjQMk2XGyED8-AIHSRpIl4izCyqc7nnmNQ2w4BwXTCYMDIM37BhbBd9qv54L1D57WWZlbVX-FlQ5p3S0axgUr-L3td9N2VWl729jiv-eWrVbz3Cinpvrnzhu_oxyGR50cYTkebQx2VE5umkrItelHyvX0Md0P9cE0YfARBqcgOgV_eY9jV62KyjY3SQ3ebiDSjHmf9W4fYvyHq7ow |
linkProvider | Royal Society of Chemistry |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=The+protective+effects+of+beta-mangostin+against+sodium+iodate-induced+retinal+ROS-mediated+apoptosis+through+MEK%2FERK+and+p53+signaling+pathways&rft.jtitle=Food+%26+function&rft.au=Chang%2C+Yuan-Yen&rft.au=Wang%2C+Meilin&rft.au=Yeh%2C+Jui-Hsuan&rft.au=Tsou%2C+Shang-Chun&rft.date=2023-12-11&rft.issn=2042-650X&rft.eissn=2042-650X&rft.volume=14&rft.issue=24&rft.spage=10896&rft_id=info:doi/10.1039%2Fd3fo03568a&rft.externalDBID=NO_FULL_TEXT |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=2042-6496&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=2042-6496&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=2042-6496&client=summon |